Comparison of efficacy and safety of once- versus twice-daily insulin detemir added on to oral antidiabetics in insulin-naive type 2 diabetes patients: 24-week, crossover, treat to target trial in a single center
PRIMARY CARE DIABETES, vol.8, no.3, pp.256-264, 2014 (SCI-Expanded)
Article / Article
PRIMARY CARE DIABETES
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Bursa Uludag University Affiliated:
Aim: To compare once- versus twice-daily insulin detemir added on OADS therapy in insulin-naive type 2 diabetes patients in terms of efficacy and safety.